Home/Filings/4/0001104659-23-077528
4//SEC Filing

MacLean Alexandra 4

Accession 0001104659-23-077528

CIK 0001644963other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 1:05 PM ET

Size

5.6 KB

Accession

0001104659-23-077528

Insider Transaction Report

Form 4
Period: 2023-06-29
MacLean Alexandra
Chief Executive Officer
Transactions
  • Award

    Employee stock option (right to buy)

    2023-06-29+800,000800,000 total
    Exercise: $1.14Exp: 2033-06-29Common Stock (800,000 underlying)
Footnotes (1)
  • [F1]The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.

Issuer

AVENUE THERAPEUTICS, INC.

CIK 0001644963

Entity typeother

Related Parties

1
  • filerCIK 0001940880

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:05 PM ET
Size
5.6 KB